pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,498
stories
Sep 8, 26
A breakthrough pancreatic cancer drug won approval. They still struggle to access it
stat
Sep 8, 26
Reynolds is selling fruity new vapes unauthorized by FDA
stat
Sep 8, 26
Can Benelux turn scientific strength into larger biotech scale?
biospace
Sep 8, 26
AI will only revolutionize drug discovery and development if we play to its strengths
biospace
Sep 8, 26
Moderna and Merck’s mRNA success fuels focus on ‘scaling out and scaling down’
biospace
Sep 8, 26
Reeling from past failures, Parkinson's pipeline enters 'era of diversification'
biospace
Sep 8, 26
Inhibrx CEO says progression-free survival data leave ‘no question’ about OX40 agonist’s durability
fiercebiotech
Sep 8, 26
Recon: FDA approves AZ’s breast cancer drug over negative adcomm vote; Novartis sees setbacks for drugs targeting cholesterol, m...
raps
Sep 7, 26
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote
endpoints
Sep 7, 26
BrainChild Bio masterminds $116M series A for CAR-T's pivotal push in pediatric brain cancer
fiercebiotech
Sep 7, 26
Guardant wins FDA nod for diagnostic guiding use of AstraZeneca’s Etcamah
fiercebiotech
Sep 6, 26
Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win
fiercebiotech
Sep 4, 26
FDA Grants Accelerated Approval to a New Breast Cancer Treatment
fda press
Sep 4, 26
STAT+: Top Boston hospitals clash over Medicare Advantage network after split
stat
Sep 4, 26
Trailing rivals, AbbVie scores win with dual-acting myeloma drug
biopharma dive
Sep 4, 26
This week in charts: China deals, stock flatlines and Lilly’s M&A spree
biopharma dive
Sep 4, 26
10 life sciences startups selected for accelerator program
biospace
Sep 4, 26
STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more
stat
Sep 4, 26
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
biopharma dive
Sep 4, 26
Pfizer punts Seagen ADC, further muddying value of the $43B buyout
biospace
Sep 4, 26
AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study
biospace
Sep 3, 26
Merck's top dealmaker signals more M&A as Keytruda's patent cliff nears
endpoints
Sep 3, 26
‘Tactical athletes’ get new guidance for cardiovascular fitness
stat
Sep 3, 26
GSK wagers up to $1.3B on a different kind of cancer drug
biopharma dive
Sep 3, 26
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout
fiercebiotech
Sep 3, 26
Pfizer shares ADC rights with Medicus; RevMed updates lung cancer data
endpoints
Sep 3, 26
TScan cuts 75% of workforce while shifting focus to solid tumor program
biospace
Sep 3, 26
STAT+: Fauci speaks, and writes
stat
Sep 3, 26
RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer
biospace
Sep 3, 26
US to grant up to $125M for personalized RNA manufacturing innovation
biospace
← prev
page 14 of 50
next →
